Cargando…

Case Report: “Primary Immunodeficiency”—Severe Autoimmune Enteropathy in a Pediatric Heart Transplant Recipient Treated With Abatacept and Alemtuzumab

Disorders of immune dysregulation following heart transplantation in children have been reported; however, the management of such disorders remains uncertain and challenging. In this case report, we describe a clinical course of a child with severe autoimmune enteropathy after a heart transplant in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalaidina, Elizaveta, Utterson, Elizabeth C., Mokshagundam, Deepa, He, Mai, Shenoy, Shalini, Cooper, Megan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017746/ https://www.ncbi.nlm.nih.gov/pubmed/35450071 http://dx.doi.org/10.3389/fimmu.2022.863218

Ejemplares similares

Alemtuzumab induction in pediatric kidney transplantation
por: Kaabak, Michael M, et al.
Publicado: (2013)

Alemtuzumab-Induced Autoimmune Thyroid Dysfunction
por: Ragavan, Sharanniyan, et al.
Publicado: (2022)

Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A Paradigm of Immunodeficiency with Autoimmunity
por: Barzaghi, Federica, et al.
Publicado: (2012)

Abatacept Improves Intractable Protein-Losing Enteropathy Secondary to AA Amyloidosis in a Patient With Rheumatoid Arthritis
por: Sawamura, Masato, et al.
Publicado: (2020)

Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab
por: Wiendl, Heinz, et al.
Publicado: (2019)

Alemtuzumab Plus Cyclosporine Treatment of the Autoimmune Hemolytic Anemia in an Adult Bowel Transplant
por: Lauro, A., et al.
Publicado: (2014)

Abatacept Rescue Therapy in Kidney Transplant Recipients: A Case Series of Five Patients
por: Uro-Coste, Charlotte, et al.
Publicado: (2022)

Autoimmune Enteropathy in an Ulcerative Colitis Patient
por: Rodriguez, Nicolette J., et al.
Publicado: (2018)

Using Adalimumab to Treat Autoimmune Enteropathy
por: Trivedi, Hirsh D., et al.
Publicado: (2019)

Celiac-like Enteropathy Associated With Mycophenolate Sodium in Renal Transplant Recipients
por: Filiopoulos, Vassilis, et al.
Publicado: (2018)

Autoimmune thyroid disease following treatment with alemtuzumab for multiple sclerosis
por: Alamo, Angela, et al.
Publicado: (2019)

Anti-thyroid autoantibodies as biomarkers for alemtuzumab associated thyroid autoimmunity
por: Reindl, Markus
Publicado: (2019)

Thyroid Autoimmunity Following Alemtuzumab Treatment in Multiple Sclerosis Patients
por: Kazakou, Paraskevi, et al.
Publicado: (2021)

Alemtuzumab
por: Tridente, Giuseppe
Publicado: (2013)

Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients
por: Bank, Jonna R., et al.
Publicado: (2016)

Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres
por: Trindade, Anil J., et al.
Publicado: (2020)

Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
por: Guthoff, Martina, et al.
Publicado: (2020)

Successful treatment of enteropathy associated with common variable immunodeficiency
por: Choi, Seung Won, et al.
Publicado: (2014)

Efficacy of abatacept treatment in a patient with enteropathy carrying a variant of unsignificance in CTLA4 gene: A case report
por: Musabak, Ugur, et al.
Publicado: (2023)

Successful Treatment of Refractory Autoimmune Enteropathy With Ustekinumab
por: Scheid, Johannes F., et al.
Publicado: (2021)

Genetic Diagnosis Guides Treatment of Autoimmune Enteropathy
por: Charbit-Henrion, Fabienne, et al.
Publicado: (2023)

Atypical Manifestation of LPS-Responsive Beige-Like Anchor Deficiency Syndrome as an Autoimmune Endocrine Disorder without Enteropathy and Immunodeficiency
por: Bakhtiar, Shahrzad, et al.
Publicado: (2016)

A case of autoimmune myositis after treatment with alemtuzumab for multiple sclerosis
por: Aouad, Patrick, et al.
Publicado: (2018)

Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity
por: Ruck, Tobias, et al.
Publicado: (2022)

Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients
por: van der Zwan, Marieke, et al.
Publicado: (2020)

Case Report: Refractory Autoimmune Gastritis Responsive to Abatacept in LRBA Deficiency
por: Boz, Valentina, et al.
Publicado: (2021)

Gastrointestinal Disorder Associated with Olmesartan Mimics Autoimmune Enteropathy
por: Scialom, Sophie, et al.
Publicado: (2015)

Seronegative Adult Autoimmune Enteropathy in a Male Traveler
por: McCabe, Patrick, et al.
Publicado: (2017)

A case of autoimmune enteropathy with CTLA4 haploinsufficiency
por: Miyazaki, Haruka, et al.
Publicado: (2022)

Adult-Onset Autoimmune Enteropathy: A Case Report
por: Lorentsen, Ruben D, et al.
Publicado: (2023)

ALAIN01—Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential
por: Ruck, Tobias, et al.
Publicado: (2016)

Monitoring and management of autoimmunity in multiple sclerosis patients treated with alemtuzumab: practical recommendations
por: Devonshire, Virginia, et al.
Publicado: (2018)

Vitiligo after alemtuzumab treatment: Secondary autoimmunity is not all about B cells
por: Ruck, Tobias, et al.
Publicado: (2018)

Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab
por: Walo-Delgado, Paulette Esperanza, et al.
Publicado: (2021)

Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis
por: Sharma, Parth, et al.
Publicado: (2022)

Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure
por: Stenger, Elizabeth O., et al.
Publicado: (2023)

Rituximab and Abatacept Are Effective in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies
por: Rodina, Yulia, et al.
Publicado: (2021)

Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases
por: Brumfiel, Caitlin M., et al.
Publicado: (2020)

Alemtuzumab induction therapy in solid organ transplantation
por: Friend, Peter J
Publicado: (2013)

Protein-losing Enteropathy Due to Inferior Vena Cava Stenosis in a Liver Transplant Recipient
por: Anugwom, Chimaobi M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5o3ltm7137ffqent4ks0tou1sc